These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14516807)

  • 1. Hereditary motor and sensory neuropathy type VI with optic atrophy.
    Voo I; Allf BE; Udar N; Silva-Garcia R; Vance J; Small KW
    Am J Ophthalmol; 2003 Oct; 136(4):670-7. PubMed ID: 14516807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.
    Cohn AC; Toomes C; Potter C; Towns KV; Hewitt AW; Inglehearn CF; Craig JE; Mackey DA
    Am J Ophthalmol; 2007 Apr; 143(4):656-62. PubMed ID: 17306754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.
    Chen Y; Jia X; Wang P; Xiao X; Li S; Guo X; Zhang Q
    Mol Vis; 2013; 19():292-302. PubMed ID: 23401657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal dominant optic atrophy with asymptomatic peripheral neuropathy.
    Chalmers RM; Bird AC; Harding AE
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):195-6. PubMed ID: 8708653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.
    Hayashi T; Sasano H; Katagiri S; Tsunoda K; Kameya S; Nakazawa M; Iwata T; Tsuneoka H
    Jpn J Ophthalmol; 2017 Sep; 61(5):395-401. PubMed ID: 28668999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1.
    Payne M; Yang Z; Katz BJ; Warner JE; Weight CJ; Zhao Y; Pearson ED; Treft RL; Hillman T; Kennedy RJ; Meire FM; Zhang K
    Am J Ophthalmol; 2004 Nov; 138(5):749-55. PubMed ID: 15531309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q10 therapy in hereditary motor sensory neuropathy type VI with novel mitofusin 2 mutation.
    Takahashi R; Ikeda T; Hamaguchi A; Iwasa K; Yamada M
    Intern Med; 2012; 51(7):791-3. PubMed ID: 22466841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.
    Lee J; Jung SC; Hong YB; Yoo JH; Koo H; Lee JH; Hong HD; Kim SB; Chung KW; Choi BO
    Mol Med Rep; 2016 Jul; 14(1):33-40. PubMed ID: 27150940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alu-element insertion in an OPA1 intron sequence associated with autosomal dominant optic atrophy.
    Gallus GN; Cardaioli E; Rufa A; Da Pozzo P; Bianchi S; D'Eramo C; Collura M; Tumino M; Pavone L; Federico A
    Mol Vis; 2010 Feb; 16():178-83. PubMed ID: 20157369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.
    Votruba M; Thiselton D; Bhattacharya SS
    Br J Ophthalmol; 2003 Jan; 87(1):48-53. PubMed ID: 12488262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.
    Züchner S; De Jonghe P; Jordanova A; Claeys KG; Guergueltcheva V; Cherninkova S; Hamilton SR; Van Stavern G; Krajewski KM; Stajich J; Tournev I; Verhoeven K; Langerhorst CT; de Visser M; Baas F; Bird T; Timmerman V; Shy M; Vance JM
    Ann Neurol; 2006 Feb; 59(2):276-81. PubMed ID: 16437557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal recessive inheritance of hereditary motor and sensory neuropathy with optic atrophy.
    Chalmers RM; Riordan-Eva P; Wood NW
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):385-7. PubMed ID: 9120454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.
    Cohen L; Tzur S; Goldenberg-Cohen N; Bormans C; Behar DM; Reinstein E
    Genet Res (Camb); 2016 Jun; 98():e10. PubMed ID: 27265430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
    Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant optic atrophy: correlation between clinical and molecular genetic studies.
    Puomila A; Huoponen K; Mäntyjärvi M; Hämäläinen P; Paananen R; Sankila EM; Savontaus ML; Somer M; Nikoskelainen E
    Acta Ophthalmol Scand; 2005 Jun; 83(3):337-46. PubMed ID: 15948788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary motor and sensory neuropathy (HMSN) and optic atrophy (HMSN type VI, Vizioli).
    Weiller C; Ferbert A
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(4-5):246-9. PubMed ID: 1647219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.
    Ahmad KE; Davis RL; Sue CM
    J Neurol; 2015 Oct; 262(10):2323-8. PubMed ID: 26194196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of OPA1-related autosomal dominant optic atrophy.
    Cohn AC; Toomes C; Hewitt AW; Kearns LS; Inglehearn CF; Craig JE; Mackey DA
    Br J Ophthalmol; 2008 Oct; 92(10):1333-6. PubMed ID: 18653586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiology and ocular blood flow in a family with dominant optic nerve atrophy and a mutation in the OPA1 gene.
    Gränse L; Bergstrand I; Thiselton D; Ponjavic V; Heijl A; Votruba M; Andréasson S
    Ophthalmic Genet; 2003 Dec; 24(4):233-45. PubMed ID: 14566653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-system neurological disease is common in patients with OPA1 mutations.
    Yu-Wai-Man P; Griffiths PG; Gorman GS; Lourenco CM; Wright AF; Auer-Grumbach M; Toscano A; Musumeci O; Valentino ML; Caporali L; Lamperti C; Tallaksen CM; Duffey P; Miller J; Whittaker RG; Baker MR; Jackson MJ; Clarke MP; Dhillon B; Czermin B; Stewart JD; Hudson G; Reynier P; Bonneau D; Marques W; Lenaers G; McFarland R; Taylor RW; Turnbull DM; Votruba M; Zeviani M; Carelli V; Bindoff LA; Horvath R; Amati-Bonneau P; Chinnery PF
    Brain; 2010 Mar; 133(Pt 3):771-86. PubMed ID: 20157015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.